Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Sir Auric Goldfinger who wrote (3225)	11/10/2000 12:53:26 PM
From: StockDung	Respond to of 5582

Everyone really knows what kind of Docter he really is drenergy.com Don't get upset

To: Sir Auric Goldfinger who wrote (3225)	11/10/2000 1:02:47 PM
From: DanZ	Read Replies (4) \| Respond to of 5582

The fact of the matter is that Gum Tech has sufficient clinical data to claim that Zicam reduces the duration of the common cold by 75%. The FTC permits this claim and none of the propaganda from you and other shorts changes that. That claim will sell a lot of Zicam despite your whining and obfuscation. How's your estimate coming for dental gum and nicotine gum. You do know that they are going to start shipping nicotine gum next quarter, don't you? When do you suppose they will start shipping dental gum to the major consumer products company? Have you been able to figure out that they will immediately be profitable once they start shipping the high volumes of that gum? Did you figure out that sales of existing gum products will be accretive to earnings once the big dental gum contract pushes them over the break even point? Do you even know how to use a calculator?